{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:08:48Z","timestamp":1790341728365,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T00:00:00Z","timestamp":1179360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T00:00:00Z","timestamp":1179360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.leu.2404670","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T13:24:56Z","timestamp":1179408296000},"page":"1442-1450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia"],"prefix":"10.1038","volume":"21","author":[{"given":"D","family":"Cilloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gottardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Arruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Defilippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Carturan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Giugliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Merante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rondoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ottaviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Soverini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tiribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Pane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Saglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"a study by the GIMEMA Working Party on Chronic Myeloid Leukemia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,17]]},"reference":[{"key":"BF2404670_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00062752-200001000-00005","volume":"7","author":"BJ Bain","year":"2000","unstructured":"Bain BJ . Hypereosinophilia. Curr Opin Hematol 2000; 7: 21\u201325.","journal-title":"Curr Opin Hematol"},{"key":"BF2404670_CR2","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","volume":"83","author":"PF Weller","year":"1994","unstructured":"Weller PF, Bubley GJ . The idiopathic hypereosinophilic syndrome. Blood 1994; 83: 2759\u20132779.","journal-title":"Blood"},{"key":"BF2404670_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev.med.54.101601.152431","volume":"54","author":"F Roufosse","year":"2003","unstructured":"Roufosse F, Cogan E, Goldman M . The hypereosinophilic syndrome revisited. Annu Rev Med 2003; 54: 169\u2013184.","journal-title":"Annu Rev Med"},{"key":"BF2404670_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","volume":"99","author":"BR Vowels","year":"1992","unstructured":"Vowels BR, Cassin M, Vonderheid EC, Rook AH . Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 1992; 99: 90\u201394.","journal-title":"J Invest Dermatol"},{"key":"BF2404670_CR5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","volume":"341","author":"HU Simon","year":"1999","unstructured":"Simon HU, Plotz SG, Dummer R, Blaser K . Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999; 341: 1112\u20131120.","journal-title":"N Engl J Med"},{"key":"BF2404670_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.V84.1.349.349","volume":"84","author":"M Luppi","year":"1994","unstructured":"Luppi M, Marasca R, Morselli M, Brozzi P, Torelli G . Clonal nature of hypereosinophilic syndrome. Blood 1994; 84: 349\u2013350.","journal-title":"Blood"},{"key":"BF2404670_CR7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V93.5.1651","volume":"93","author":"HW Chang","year":"1999","unstructured":"Chang HW, Leong KH, Koh DR, Lee SH . Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood 1999; 93: 1651\u20131657.","journal-title":"Blood"},{"key":"BF2404670_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa025217","volume":"348","author":"J Cools","year":"2003","unstructured":"Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J et al. A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201\u20131214.","journal-title":"N Engl J Med"},{"key":"BF2404670_CR9","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(02)08505-7","volume":"359","author":"GJ Gleich","year":"2002","unstructured":"Gleich GJ, Leiferman KM, Pardanani A, Tefferi A, Butterfield JH . Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 2002; 359: 1577\u20131578.","journal-title":"Lancet"},{"key":"BF2404670_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.semcancer.2004.03.002","volume":"4","author":"S Coutre","year":"2004","unstructured":"Coutre S, Gotlib J . Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate. Semin Cancer Biol 2004; 4: 307\u2013315.","journal-title":"Semin Cancer Biol"},{"key":"BF2404670_CR11","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","volume":"104","author":"A Pardanani","year":"2004","unstructured":"Pardanani A, Brockman SR, Paternoster SF, Flynn HC, Ketterling RP, Lasho TL et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 2004; 104: 3038\u20133045.","journal-title":"Blood"},{"key":"BF2404670_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.seminoncol.2004.03.035","volume":"31","author":"RM Stone","year":"2004","unstructured":"Stone RM, Gilliland DG, Klion AD . Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome. Semin Oncol 2004; 31: 12\u201317.","journal-title":"Semin Oncol"},{"key":"BF2404670_CR13","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1182\/blood-2003-06-1824","volume":"103","author":"J Gotlib","year":"2004","unstructured":"Gotlib J, Cools J, Malone JM, Schrier SL, Gilliland DJ, Coutre SE . The FIP1L1-PDGFRa fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2004; 103: 2879\u20132888.","journal-title":"Blood"},{"key":"BF2404670_CR14","first-page":"486","volume":"85","author":"R Bigoni","year":"2000","unstructured":"Bigoni R, Cuneo A, Roberti MG, Dilani R, Bardi A, Cavazzini F et al. Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome. Haematologica 2000; 85: 486\u2013491.","journal-title":"Haematologica"},{"key":"BF2404670_CR15","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.7326\/0003-4819-68-6-1220","volume":"68","author":"WR Hardy","year":"1968","unstructured":"Hardy WR, Anderson RE . The hypereosinophilic syndromes. Ann Intern Med 1968; 68: 1220\u20131229.","journal-title":"Ann Intern Med"},{"key":"BF2404670_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(90)90601-A","volume":"60","author":"KM Call","year":"1990","unstructured":"Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990; 60: 509\u2013520.","journal-title":"Cell"},{"key":"BF2404670_CR17","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/sj.leu.2403817","volume":"19","author":"U Keilholz","year":"2005","unstructured":"Keilholz U, Menssen HD, Gaiger A, Menke A, Oji Y, Oka Y et al. Wilms' tumour gene 1 (WT1) in human neoplasia. Leukemia 2005; 19: 1318\u20131323.","journal-title":"Leukemia"},{"key":"BF2404670_CR18","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1200\/JCO.2003.10.503","volume":"21","author":"D Cilloni","year":"2003","unstructured":"Cilloni D, Gottardi E, Messa F, Fava M, Scaravaglio P, Bertini M et al. Significant correlation between the degree of WT1 expression level and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. J Clin Oncol 2003; 21: 1988\u20131995.","journal-title":"J Clin Oncol"},{"key":"BF2404670_CR19","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V89.4.1405","volume":"89","author":"K Inoue","year":"1997","unstructured":"Inoue K, Ogawa H, Sonoda Y, Kimura T, sakabe H, Oka Y et al. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukaemia. Blood 1997; 89: 1405\u20131412.","journal-title":"Blood"},{"key":"BF2404670_CR20","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1038\/sj.leu.2402675","volume":"16","author":"D Cilloni","year":"2002","unstructured":"Cilloni D, Gottardi E, De Micheli D, Serra A, Volpe G, Messa F et al. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 2002; 16: 2115\u20132121.","journal-title":"Leukemia"},{"key":"BF2404670_CR21","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1182\/blood.V88.6.2267.bloodjournal8862267","volume":"88","author":"K Inoue","year":"1996","unstructured":"Inoue K, Ogawa H, Yamagami T, Soma T, Tani Y, Tatekawa T et al. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 1996; 88: 2267\u20132278.","journal-title":"Blood"},{"key":"BF2404670_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1053\/shem.2003.50040","volume":"40","author":"D Cilloni","year":"2003","unstructured":"Cilloni D, Saglio G . Usefulness of quantitative assessment of Wilms tumor suppressor gene expression in chronic myeloid leukaemia patients undergoing Imatinib therapy. Semin Hematol 2003; 40: 37\u201341.","journal-title":"Semin Hematol"},{"key":"BF2404670_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF02983561","volume":"78","author":"H Tamaki","year":"2003","unstructured":"Tamaki H, Mishima M, Kawakami M, Tsuboi A, Kim EH, Hosen N et al. Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1). Int J Hematol 2003; 78: 349\u2013356.","journal-title":"Int J Hematol"},{"key":"BF2404670_CR24","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1182\/blood-2002-06-1831","volume":"101","author":"H Ogawa","year":"2003","unstructured":"Ogawa H, Tamaki H, Ikegame K, Soma T, Kawakami M, Tsuboi A et al. The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia. Blood 2003; 101: 1698\u20131704.","journal-title":"Blood"},{"key":"BF2404670_CR25","volume-title":"World Health Organization Classification of Tumors: tumours of the hematopoietic and lymphoid tissues","author":"B Bain","year":"2001","unstructured":"Bain B, Pierre R, Imbert M . Chronic eosinophilic leukemia and the hypereosinophilic syndrome. In: IARC (ed) World Health Organization Classification of Tumors: tumours of the hematopoietic and lymphoid tissues. International Agency for Research in Cancer (IARC) Press: Lyon, France, 2001."},{"key":"BF2404670_CR26","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","volume":"13","author":"JJ Van Dongen","year":"1999","unstructured":"Van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901\u20131928.","journal-title":"Leukemia"},{"key":"BF2404670_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1385\/1-59745-017-0:199","volume":"125","author":"D Cilloni","year":"2005","unstructured":"Cilloni D, Gottardi E, Saglio E . WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromes. Myeloid Leukemia: Methods and Protocols 2005; 125: 199\u2013211.","journal-title":"Myeloid Leukemia: Methods and Protocols"},{"key":"BF2404670_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-2141.2006.06038.x","volume":"133","author":"A Tefferi","year":"2006","unstructured":"Tefferi A, Patnaik MA, Pardanani A . Eosinophilia: secondary, clonal and idiopathic. Br J Haematol 2006; 133: 468\u2013492.","journal-title":"Br J Haematol"},{"key":"BF2404670_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/10428190310001641143","volume":"45","author":"P Musto","year":"2004","unstructured":"Musto P, Falcone A, Sanpaolo G, Bodenizza C, Perla G, Minervini MM et al. Heterogeneity of response to imatinib-mesylate (glivec) in patients with hypereosinophilic syndrome: implications for dosing and pathogenesis. Leuk Lymphoma 2004; 45: 1219\u20131222.","journal-title":"Leuk Lymphoma"},{"key":"BF2404670_CR30","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1600-0609.1975.tb02432.x","volume":"14","author":"F Mitelman","year":"1975","unstructured":"Mitelman F, Panani A, Brandt L . Isochromosome 17 in a case of eosinophilic leukaemia. An abnormality common to eosinophilic and neutrophilic cells. Scand J Haematol 1975; 14: 308\u2013312.","journal-title":"Scand J Haematol"},{"key":"BF2404670_CR31","first-page":"149","volume":"4","author":"SW Needleman","year":"1990","unstructured":"Needleman SW, Mane SM, Gutheil JC, Kapil V, Heyman MR, Testa JR . Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to lossof y chromosome and c-N-ras activation. Hematol Pathol 1990; 4: 149\u2013155.","journal-title":"Hematol Pathol"},{"key":"BF2404670_CR32","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1038\/sj.onc.1203190","volume":"18","author":"T Sjoblom","year":"1999","unstructured":"Sjoblom T, Boureux A, Ronnstrand L, Heldin CH, Ghysdael J, Ostman A . Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF betaR fusion protein. Oncogene 1999; 18: 7055\u20137062.","journal-title":"Oncogene"},{"key":"BF2404670_CR33","first-page":"97","volume":"4","author":"DA Haber","year":"1992","unstructured":"Haber DA, Buckler AJ . WT1: a novel tumor suppressor gene inactivated in Wilms' tumor. New Biol 1992; 4: 97\u2013106.","journal-title":"New Biol"},{"key":"BF2404670_CR34","first-page":"105","volume":"12","author":"DA Haber","year":"1992","unstructured":"Haber DA, Housman DE . Role of the WT1 gene in Wilms' tumour. Cancer Surv 1992; 12: 105\u2013117.","journal-title":"Cancer Surv"},{"key":"BF2404670_CR35","first-page":"312","volume":"25","author":"PN Baird","year":"1997","unstructured":"Baird PN, Simmons PJ . Expressin of the Wilms' tumor gene (WT1) in normal hemopoiesis. Exp Hematol 1997; 25: 312\u2013320.","journal-title":"Exp Hematol"},{"key":"BF2404670_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.leu.2401341","volume":"13","author":"H Tamaki","year":"1999","unstructured":"Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki JH, Iwama H, Inoue H et al. The Wilms' tumor gene is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia 1999; 13: 393\u2013399.","journal-title":"Leukemia"},{"key":"BF2404670_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1182\/blood.V100.1.22","volume":"100","author":"T Shichishima","year":"2002","unstructured":"Shichishima T, Okamoto M, Ikeda K, Kaneshige T, Sugiyama H, Terasawa T et al. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 2002; 100: 22\u201328.","journal-title":"Blood"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404670","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404670.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:21:42Z","timestamp":1648779702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,17]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF2404670"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404670","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,17]]},"assertion":[{"value":"3 January 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}